Mirum Pharmaceuticals Inc (MIRM)
41.64
-0.42
(-0.99%)
USD |
NASDAQ |
Jan 08, 12:42
Mirum Pharmaceuticals SG&A Expense (Quarterly): 50.54M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Cytokinetics Inc | 56.65M |
| Amicus Therapeutics Inc | 75.11M |
| Ocugen Inc | 6.28M |
| Scholar Rock Holding Corp | 16.06M |
| Arcutis Biotherapeutics Inc | 58.82M |